ATE276766T1 - Chemotherapeutische zusammensetzung und verfahren - Google Patents
Chemotherapeutische zusammensetzung und verfahrenInfo
- Publication number
- ATE276766T1 ATE276766T1 AT99957794T AT99957794T ATE276766T1 AT E276766 T1 ATE276766 T1 AT E276766T1 AT 99957794 T AT99957794 T AT 99957794T AT 99957794 T AT99957794 T AT 99957794T AT E276766 T1 ATE276766 T1 AT E276766T1
- Authority
- AT
- Austria
- Prior art keywords
- dna
- cancer cells
- phlei
- mcc
- methods
- Prior art date
Links
- 230000000973 chemotherapeutic effect Effects 0.000 title 1
- 206010028980 Neoplasm Diseases 0.000 abstract 4
- 201000011510 cancer Diseases 0.000 abstract 4
- 210000004027 cell Anatomy 0.000 abstract 4
- 241000187481 Mycobacterium phlei Species 0.000 abstract 3
- 239000002246 antineoplastic agent Substances 0.000 abstract 2
- 229940127089 cytotoxic agent Drugs 0.000 abstract 2
- 230000000118 anti-neoplastic effect Effects 0.000 abstract 1
- 230000006907 apoptotic process Effects 0.000 abstract 1
- 230000025084 cell cycle arrest Effects 0.000 abstract 1
- 210000002421 cell wall Anatomy 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 229940055036 mycobacterium phlei Drugs 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
- 230000002062 proliferating effect Effects 0.000 abstract 1
- 230000035755 proliferation Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11101998P | 1998-12-04 | 1998-12-04 | |
| US12732099P | 1999-04-01 | 1999-04-01 | |
| PCT/CA1999/001157 WO2000033875A1 (en) | 1998-12-04 | 1999-12-03 | Chemotherapeutic composition and method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE276766T1 true ATE276766T1 (de) | 2004-10-15 |
Family
ID=26808584
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99957794T ATE276766T1 (de) | 1998-12-04 | 1999-12-03 | Chemotherapeutische zusammensetzung und verfahren |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP1135161B1 (de) |
| JP (1) | JP4380922B2 (de) |
| AT (1) | ATE276766T1 (de) |
| AU (1) | AU782335B2 (de) |
| CA (1) | CA2353905C (de) |
| DE (1) | DE69920506T2 (de) |
| DK (1) | DK1135161T3 (de) |
| ES (1) | ES2229792T3 (de) |
| NZ (1) | NZ511941A (de) |
| PT (1) | PT1135161E (de) |
| WO (1) | WO2000033875A1 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6794368B1 (en) | 1999-04-01 | 2004-09-21 | Bioniche Life Sciences Inc. | Composition and method for inducing apoptosis in prostate cancer cells |
| EP1250152B1 (de) | 1999-12-28 | 2013-05-15 | Bioniche Urology IP Inc. | Hyaluronsäure enthaltende synergistische Zusammensetzung zur Krebsbehandlung |
| AU2011315093B2 (en) * | 2010-10-13 | 2013-10-17 | Telesta Therapeutics Ip Inc. | Bacterial ribonucleic acid cell wall compositions and methods of making and using them |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4335435B2 (ja) * | 1997-08-05 | 2009-09-30 | バイオニケ ライフ サイエンシーズ インコーポレイテッド | 細胞増殖および細胞死を調節する組成物および方法 |
-
1999
- 1999-12-03 WO PCT/CA1999/001157 patent/WO2000033875A1/en not_active Ceased
- 1999-12-03 DK DK99957794T patent/DK1135161T3/da active
- 1999-12-03 PT PT99957794T patent/PT1135161E/pt unknown
- 1999-12-03 EP EP99957794A patent/EP1135161B1/de not_active Expired - Lifetime
- 1999-12-03 DE DE69920506T patent/DE69920506T2/de not_active Expired - Lifetime
- 1999-12-03 ES ES99957794T patent/ES2229792T3/es not_active Expired - Lifetime
- 1999-12-03 NZ NZ511941A patent/NZ511941A/xx not_active IP Right Cessation
- 1999-12-03 AT AT99957794T patent/ATE276766T1/de active
- 1999-12-03 JP JP2000586365A patent/JP4380922B2/ja not_active Expired - Fee Related
- 1999-12-03 CA CA2353905A patent/CA2353905C/en not_active Expired - Fee Related
- 1999-12-03 AU AU15412/00A patent/AU782335B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| DE69920506T2 (de) | 2005-10-13 |
| DK1135161T3 (da) | 2005-01-24 |
| JP2002531524A (ja) | 2002-09-24 |
| PT1135161E (pt) | 2005-01-31 |
| WO2000033875A1 (en) | 2000-06-15 |
| EP1135161B1 (de) | 2004-09-22 |
| EP1135161A1 (de) | 2001-09-26 |
| AU782335B2 (en) | 2005-07-21 |
| JP4380922B2 (ja) | 2009-12-09 |
| NZ511941A (en) | 2003-04-29 |
| ES2229792T3 (es) | 2005-04-16 |
| DE69920506D1 (de) | 2004-10-28 |
| AU1541200A (en) | 2000-06-26 |
| CA2353905A1 (en) | 2000-06-15 |
| CA2353905C (en) | 2010-06-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO983429L (no) | Anvendelse av et texaphyrin til fremstilling av et medikament for anvendelse med et kjemoterapeutisk middel i kreftkjemosensitivisering | |
| CY1118316T1 (el) | Θεραπεια συμπαγων νεφρικων ογκων με ενα παραγωγο ραπαμυκινης | |
| DK1093819T3 (da) | Forbindelse og præparat til tilförsel af aktive midler | |
| AP2001002109A0 (en) | Chemotherapy of cancer with acetyldinaline in combination with gemcitabine, capecitabine or cisplatin. | |
| TR199900885T2 (xx) | Tedavi ama�l� izoflavonlar i�eren y�ntemler ve bile�ikler. | |
| PT1154998E (pt) | Inibidores da formação de mononucleótido de niacinamida celular e sua utilização em terapia do cancro | |
| ATE312080T1 (de) | 2-chinolonen enthaltende arzneimittel | |
| MXPA01008465A (es) | Complejos de anticuerpo de quimiocina biotinilada. | |
| TR199701147T1 (xx) | Kanserlerin geli�mesini �nlemeye mahsus, benzimidazol i�eren bir farmas�tik bile�im. | |
| EP2020237A3 (de) | Ceramidmittel und Chemotherapeutika zur Herbeiführung des Zelltodes | |
| WO2002030465A3 (en) | Compositions that inhibit proliferation of cancer cells | |
| AU6737900A (en) | The hematopoietic, myeloprotecting, antitumor immune cells generating and radiosensitizing polysaccharide isolated from panax ginseng | |
| ATE290388T1 (de) | Kombination von selen-haltigen verbindungen mit gemcitabin oder mitomycin c | |
| DE69920506D1 (de) | Chemotherapeutische zusammensetzung und verfahren | |
| ZA200104529B (en) | Topical compositions comprising ascomycins. | |
| TR200503846T2 (tr) | Değiştirilmiş salimli ensülin sensitizörü için fterkip ve kullanımı | |
| NO20021048D0 (no) | Chalconkumariner | |
| DE69917796D1 (de) | Decursin-enthaltende pharmazeutische zusammensetzungen | |
| NO20012027L (no) | Fremgangsmåter og blandinger for selektiv kreft-kjemoterapi | |
| DK1054680T3 (da) | Behandling af blærecancer med mycobacterium phlei cellevæg | |
| MXPA03003798A (es) | Derivados triciclicos de indol con actividad antiangiogenica. | |
| FR2326432A1 (fr) | Polymere de diene conjugue contenant un agent contre le durcissement | |
| ATE323475T1 (de) | D-methionin zur reduzierung der toxizität von platin-enthaltenden antitumor verbindungen | |
| DE60003560D1 (de) | 1,2-dihydro-1-oxo-pyrazino[1,2-]indolederivate | |
| DK1135164T3 (da) | Sammensætning til behandling af inflammation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1135161 Country of ref document: EP |